Back to Oncology Drug index

Back to Mitotic inhibitors

Name: Vincristine sulfate

Pregnancy Category D

Drug classes

  • Mitotic inhibitor
  • Antineoplastic agent

Therapeutic actions

Mitotic inhibitor: arrests mitotic division at the stage of metaphase; exact mechanism of action unknown.

Indications

Acute leukemia

Hodgkin's disease, Non-Hodgkin's lymphoma, multiple myeloma, lymphosarcoma, reticulum cell sarcoma, rhabdomyosarcoma, neuroblastoma, bladder cancer, Wilms' tumor as part of combination therapy

Unlabeled uses: idiopathic thrombocytopenic purpura

Contraindications/cautions

Contraindicated in the presence of allergy to vincristine, leukopenia, acute infection, pregnancy, lactation.

Use caution in the presence of neuromuscular disease, diabetes insipidus, hepatic dysfunction.

Adverse effects

  • CNS: Ataxia, cranial nerve manifestations; foot drop, headache, convulsions, bladder neuropathy, paresthesias, sensory impairment, neuritic pain, muscle wasting, SIADH, optic atrophy, transient cortical blindness, ptosis, diplopia, photophobia
  • GI: Constipation, oral ulcerations, abdominal cramps, vomiting, diarrhea, intestinal necrosis
  • Hematologic: Leukopenia
  • GU: Acute uric acid nephropathy, polyuria, dysuria
  • Local: Local irritation, cellulitis if extravasation occurs
  • Other: Weight loss, loss of hair, fever, death with serious overdosage

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

  • Ask a Doctor Teams: Respond to patient questions and discuss challenging presentations with other members.

Doctors Lounge Membership Application

Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us